How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q2 2017?

45 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q2 2017. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 27,995,500
Total 13F shares: 10,799,619
Share change: +2,708,712
Total reported value: $173,764,545
Price per share: $16.09
Number of holders: 45
Value change: +$43,612,075
Number of buys: 33
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 87184Q107:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Flagship Pioneering, LLC	13F	Company	17%	4,806,656	$76,570,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	13%	3,508,937	$55,897,000	—	31 Mar 2017	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5.8%	1,615,136	$25,729,000	—	31 Mar 2017	13F
Redmile Group, LLC	13F	Company	3.4%	952,740	$15,177,000	—	31 Mar 2017	13F
Aisling Capital LLC	13F	Company	1.8%	508,565	$8,101,000	—	31 Mar 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	0.73%	204,465	$3,257,000	—	31 Mar 2017	13F
Casdin Capital, LLC	13F	Company	0.65%	182,141	$2,902,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	0.64%	179,368	$2,857,000	—	31 Mar 2017	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.54%	150,000	$2,390,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	0.47%	132,096	$2,104,000	—	31 Mar 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.43%	120,556	$1,921,000	—	31 Mar 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.41%	113,826	$1,813,000	—	31 Mar 2017	13F
EcoR1 Capital, LLC	13F	Company	0.23%	63,596	$1,013,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.22%	61,247	$976,000	—	31 Mar 2017	13F
AWM Investment Company, Inc.	13F	Company	0.17%	47,550	$757,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	40,058	$638,000	—	31 Mar 2017	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.14%	40,000	$637,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.12%	33,098	$527,000	—	31 Mar 2017	13F
Opaleye Management Inc.	13F	Company	0.09%	25,149	$400,000	—	31 Mar 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.05%	14,100	$225,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	11,646	$186,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.04%	11,642	$185,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.04%	10,832	$173,000	—	31 Mar 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	9,600	$153,000	—	31 Mar 2017	13F
GLENMEDE TRUST CO NA	13F	Company	0.03%	9,324	$148,000	—	31 Mar 2017	13F
ARK Investment Management LLC	13F	Company	0.03%	8,245	$131,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	5,001	$80,000	—	31 Mar 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.02%	4,933	$79,000	—	31 Mar 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	4,608	$73,000	—	31 Mar 2017	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	2,867	$46,000	—	31 Mar 2017	13F
Nationwide Fund Advisors	13F	Company	0.01%	2,008	$32,000	—	31 Mar 2017	13F
STRS OHIO	13F	Company	0.01%	1,500	$23,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0%	1,146	$18,000	—	31 Mar 2017	13F
Creative Planning	13F	Company	0%	975	$16,000	—	31 Mar 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	824	$13,000	—	31 Mar 2017	13F
UBS Group AG	13F	Company	0%	779	$12,000	—	31 Mar 2017	13F
ROYAL BANK OF CANADA	13F	Company	0%	599	$10,000	—	31 Mar 2017	13F
Legal & General Group Plc	13F	Company	0%	583	$9,000	—	31 Mar 2017	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	366	$6,000	—	31 Mar 2017	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	242	$4,000	—	31 Mar 2017	13F
CITIGROUP INC	13F	Company	0%	124	$2,000	—	31 Mar 2017	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	100	$1,593	—	31 Mar 2017	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	93	$1,000	—	31 Mar 2017	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	49	$1,000	—	31 Mar 2017	13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2017

As of 30 Jun 2017, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,799,619 shares. The largest 10 holders included FMR LLC, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Aisling Capital LLC, VANGUARD GROUP INC, Cormorant Asset Management, LLC, and Casdin Capital, LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.